WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Visitors are seen on camera damaging rock formations at a Nevada recreation siteThick blanket of fog in Pakistan's capital affects routine lifeU.S. transportation authority report finds missing bolts in Boeing door plug blowoutIndia's Delhi, outskirts mandate StageUnited Airlines Boeing 757 flight makes emergency landing due to wing damageI blocked off my driveway with £34 tool from ScrewfixDay 3 of the Masters at a glanceIndia's Delhi, outskirts mandate StageChinese experts help farmers in Cote d'Ivoire achieve bumper harvest of paddy riceUNGA convenes meeting following U.S. veto on Gaza in Security Council
3.2161s , 6515.03125 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,World Weaver news portal